\
&
Contact us
\
&
Contact us
Published on | 3 months ago
ProgrammesThe Fast Track Programme of the European Partnership for Personalised Medicine (EP PerMed) offers support to start-ups and small teams and researchers at a pivotal stage of development, ensuring that promising personalised medicine (PM) innovations do not stall due to lack of validation resources and guidance.
The Fast Track Programme offers targeted support to accelerate the validation and adoption of innovative PM solutions. The programme helps early-stage innovators progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.
More information, including the call text and details how to apply & evaluation process are available here. The deadline to submit your application is 10 March 2026. An information webinar on the Fast Track call will take place on 20 January and a final Q&A session on 3 March.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The following call topics under the Digital Europe programme are now open for submission: Apply AI: Piloting AI-based image screening in medical centres Digital solutions for regulatory compliance through data Advanced Digital Skills for AI Uptake in Health EdTech Accelerator Digital Skills and Jobs Platform: The National Coalitions for Digi... read more
Professor Inez Germeys leads the Center for Contextual Psychiatry at KU Leuven, which is a large multi-disciplinary research group focusing on the interaction between the person and the environment in the development of psychopathology. She has received a European Research Council (ERC) Consolidator grant (INTERACT) and Proof of Concept grant (IMPACT). With these grants professor Germeys and her team researched a new mobile self-management therapy for patients with a psychotic disorder. The Acceptance and Commitment Therapy in Daily Life (ACT-DL) was further developed for the clinical environment. In line with that the Horizon 2020 IMMERSE project aims to thoroughly evaluate strategies, processes, and outcomes of implementing a digital mobile mental health solution.
